Lotus Pharm vs Synmosa Biopharma: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and Synmosa Biopharma (4114) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ Synmosa Biopharma

0%+226%-22%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYSynmosa BiopharmaYoY
Oct 2026NT$2.13 billion-22.5%NT$766.6 million+41.2%
Sep 2026NT$2.77 billion+128.0%NT$747 million+38.7%
Aug 2026NT$2.11 billion+81.7%NT$754.3 million+49.9%
Jul 2026NT$2.49 billion+3.9%NT$791.7 million+59.8%
Jun 2026NT$3.4 billion+225.5%NT$750.9 million+30.7%
May 2026NT$2.32 billion+105.8%NT$600.8 million+12.9%
Apr 2026NT$3.09 billion+19.9%NT$570.4 million+13.5%
Mar 2026NT$4.35 billion+173.6%NT$562.6 million+17.3%
Feb 2026NT$2.24 billion+131.5%NT$430.3 million-7.8%
Jan 2026NT$2.05 billion-5.5%NT$634.9 million+25.4%
Dec 2025NT$2.44 billion+66.9%NT$543.7 million+4.3%
Nov 2025NT$1.06 billion-0.2%NT$502.6 million+0.9%
Oct 2025NT$2.75 billion+46.0%NT$543 million+9.2%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16